SPH7485

· Shanghai Pharmaceuticals Holding Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPH7485, covering 2025-08-17 to 2025-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors. [Phase 1]